Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study-Reference-Cited by-同舟云学术

Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study

Published:2022-12 Issue:12 Volume:22 Page:1737-1747
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Swarthout Todd D,Henrion Marc Y R,Thindwa Deus,Meiring James E,Mbewe Maurice,Kalizang’Oma Akuzike,Brown Comfort,Msefula Jacquline,Moyo Brewster,Mataya Andrew A,Barnaba Susanne,Pearce Emma,Gordon Melita,Goldblatt David,French Neil,Heyderman Robert S

Funder

Wellcome Trust

Government of the United Kingdom

National Institute for Health and Care Research

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference34 articles.

1. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016;Lancet Infect Dis,2018

2. Mechanisms of naturally acquired immunity to Streptococcus pneumoniae;Ramos-Sevillano;Front Immunol,2019